# The gene that explains why some families age better than others

> A study of exceptionally long-lived families has identified rare genetic variants that could help certain people stay in better health for much

- Author: Maxime Marquette
- Publisher: MadMax (https://mad-max.co)
- Section: Investigation
- Published: 2026-07-05
- Canonical URL: https://mad-max.co/en/article/le-gene-qui-explique-pourquoi-certaines-familles-vieillissent-mieux-que-d-autres

## Key takeaways

- The findings were presented at the European Society of Human Genetics conference in Gothenburg, as part of the Leiden Longevity Study.
- Researchers analyzed 212 groups of long-lived siblings, narrowing the search to about 350 genes and identifying twelve rare protein-altering variants.
- The CGAS variant appeared in only two families, a signal the researchers consider worth further investigation.
- The proposed mechanism is that family members may have carried one active copy of CGAS, dampening chronic inflammation while still allowing immune defense.
- Next steps include testing the mutation in killifish, a short-lived fish, to see whether it extends lifespan.

## Introduction: a rare genetic clue found in exceptional families

### A discovery presented to the European scientific community

A study of exceptionally long-lived **families** has identified rare genetic variants that could help certain people stay in better **health** for much longer as they age. The findings, presented at the annual conference of the **European Society of Human Genetics** in **Gothenburg**, highlight a particular **mutation** in the **CGAS** gene (cyclic GMP-AMP synthase), which appears to dampen the chronic **inflammation** linked to aging.

This **research** was led by a team at the **Leiden University Medical Center** in the Netherlands, as part of the **Leiden Longevity Study**, a **research** cohort that has followed **families** for years in which several members reached an advanced age in excellent **health**.

*I find it fascinating that longevity science is finally turning to whole families instead of isolated individuals: it strikes me as an approach far closer to the real complexity of human aging.*

## Twelve rare variants in a sea of twenty thousand genes

### Methodical research that narrows the field of possibilities

The **research** team analyzed **212 groups of long-lived siblings**, meaning sets of **brothers** and sisters sharing the same two parents who all reached an advanced age. This analysis identified **four regions** of the **genome** likely to contain genes linked to **longevity**, narrowing the search field to roughly **350 genes** rather than the roughly **20,000 genes** that make up the full human genome.

Among these targeted regions, **researchers** isolated **twelve rare protein-altering genetic variants**, one of which, located on the **CGAS** gene, turned out to be present in two distinct long-lived families included in the study — a statistical signal strong enough to justify further investigation.

### The already-established link between long-lived parents and cardiometabolic health

This discovery builds on earlier work by the same team, which had already shown that middle-aged people whose parents had lived long lives developed **cardiometabolic** **diseases** on average **thirteen years later** than their partners whose parents had shorter life expectancies — a considerable gap suggesting a strong hereditary **genetic** component to the quality of **aging**.

This continuity of **research** strengthens the credibility of the new finding on the **CGAS** gene, since it fits within an already solid body of **evidence** on the heritability of healthy **longevity** within certain **family** lines.

*A thirteen-year gap in the onset of **cardiometabolic** **diseases** between two otherwise comparable groups of people — that is the kind of number that convinces me longevity **genetics** deserves every dollar of public funding it gets.*

## How a single copy of a gene can change everything

### The biological mechanism behind the dampened inflammation

The **CGAS** gene normally acts as an **immune** sentinel: it triggers an inflammatory response when it detects **DNA** in the wrong place inside a **cell**, an essential **defense** mechanism that can, with age, become excessive and contribute to what **researchers** call low-grade chronic **inflammation**, a recognized driver of many **aging**-related **diseases**.

According to **Pasquale Putter**, a final-year PhD candidate in Professor **Eline Slagboom's** group at **Leiden**, members of the families studied likely carried a single active copy of the **CGAS** gene rather than two, which would have reduced their inflammatory response while remaining sufficient to fight infections and repair cellular damage.

### A delicate balance between protection and immune defense

This balancing mechanism, if confirmed, would illustrate a fascinating **principle** of **aging** biology: the key to **healthy** longevity may lie not in eliminating certain biological mechanisms entirely, but in fine-tuning them — active enough to protect the body without itself becoming a source of long-term damage.

**Putter** explained that this calibrated reduction in **inflammation** would contribute to the protective mechanisms that extend **healthy lifespan**, or **healthspan**, defined in this research as the number of years a person lives without chronic disease or significant cognitive decline.

*Let me simplify a complex idea here: this isn't about wiping out our **immune** system to live longer, but about tuning it more finely — a crucial nuance that catchy longevity headlines often forget to mention.*

## Next steps: fish to unlock the human mystery

### The killifish, the ideal test subject for accelerated aging

The **research** team plans to introduce the **CGAS** gene **mutation** into the **killifish**, a fish recognized as the **vertebrate** with the shortest natural lifespan, just **three to nine months**, making it an ideal model for quickly observing the effects of a genetic **mutation** on **longevity** without waiting decades as would be necessary with classic **mammalian** models.

This approach will help determine whether the **mutation** truly contributes to an extended lifespan compared with control groups, while also studying its effects on the health of different tissues — a crucial step before considering any future human application of this discovery.

### An experimental surprise fueling scientific enthusiasm

**Putter** revealed that the team had been surprised by the magnitude of the CGAS mutation's effect observed in laboratory experiments conducted so far, an encouraging signal that justifies investment in the next stages of research, notably the **killifish** studies and the exploration of other candidate variants identified in the **Leiden** Longevity Study.

This methodological caution, favoring gradual validation across several biological models before drawing any definitive conclusion, reflects the scientific rigor needed in a research field where premature announcements have historically often disappointed the public.

*I am deliberately cautious here: going from an interesting mutation in fish to a treatment applicable to humans generally takes years, if not decades, and I refuse to feed a false hope of an imminent miracle pill.*

## What this discovery means, and what it does not mean yet

### A promising lead, not an available treatment

It is essential to clarify, to avoid any dangerous confusion, that this discovery in no way constitutes an available **treatment** or gene **therapy** for the general public. It is a fundamental scientific observation that opens a promising research avenue, but whose eventual **clinical** applications, if they ever materialize, would remain years away from development, safety testing and rigorous **clinical trials**.

Professor **Alexandre Reymond**, chair of the conference where these results were presented, summarized the scientific stakes by noting that these findings allow the research community to focus on factors linked to longevity and, more importantly, to identify what could be key elements for extending healthy lifespan across the general population.

### A family-based approach that could transform genetic research

**Putter** stressed that this whole-family approach, rather than studying isolated individuals, could help distinguish environmental factors from truly genetic ones, particularly when rare mutations are involved — a crucial methodological distinction to avoid wrongly attributing to genetics effects that actually stem from lifestyle or a shared family environment.

This methodology could, if successfully replicated in other international cohorts, pave the way for identifying many other similar genetic variants, gradually drawing a more complete map of the biological mechanisms underlying healthy human aging.

*I welcome this rigor, which clearly separates the scientific lead from any miracle cure: it's exactly the kind of honest science communication longevity research deserves, far from the exaggerated promises that circulate all too often online.*

## The broader context of Western longevity research

### A booming field driven by demographic aging

This discovery fits into a context where **longevity** research is experiencing considerable growth across the Western world, driven both by the demographic **aging** of European and North American populations and by growing private **investment** from tech entrepreneurs convinced of the commercial and societal potential of this emerging science.

European academic institutions, such as the **Leiden** University Medical Center, play an important role in this field by maintaining a rigorous, public-facing approach to research, in contrast with some private American initiatives sometimes criticized for over-promising commercial results before full scientific validation.

### A global scientific competition that now includes China

It's worth noting that **China** is also investing massively in biomedical aging research, with declared ambitions of global scientific leadership in this field by the end of the decade, which reinforces the importance for Western institutions, such as those in the Netherlands, of maintaining a strong pace of publication and international collaboration.

This international scientific competition, though sometimes framed in terms of geopolitical rivalry, ultimately benefits all of humanity if it translates into an acceleration of discoveries that benefit global public health, a goal that transcends national borders in this particular field of medical research.

*I prefer to see this global scientific race on longevity as a collaborative effort that benefits humanity rather than a mere geopolitical duel, though I remain mindful that I want the West to keep its lead in this strategic field.*

## The methodological limits the researchers themselves acknowledge

### A sample still too small for definitive conclusions

Despite the enthusiasm surrounding this discovery, it's worth remembering that the CGAS **variant** was identified in only two long-lived **families** out of the **212** sibling groups studied, a **sample** still too small to warrant generalizing this observation to the entire population, or even to all exceptionally long-lived families worldwide.

The **Leiden** **researchers** themselves are transparent about this methodological limitation, insisting on the need to validate this discovery through animal models like the **killifish** before considering any broader extrapolation about the real scope of this genetic **variant** in the general population.

### The persistent difficulty of separating genetics from lifestyle

Another significant limitation concerns the inherent difficulty of fully distinguishing purely genetic effects from lifestyle factors shared within a family, such as diet, physical activity or socio-economic environment, all of which can contribute to longevity independently of any specific genetic mutation.

This methodological complexity explains why researchers now favor studying entire families rather than isolated individuals, an approach that helps better isolate the genetic component by comparing people who share a similar family environment but have slightly different genetic profiles.

*I respect this scientific honesty that openly acknowledges its own methodological limits, a quality too rare in a research field where the temptation of a spectacular announcement is constant.*

## What this research could mean for preventive medicine

### Toward targeted genetic tests to anticipate inflammatory aging

If future research confirms the **protective** role of the CGAS **variant**, one can imagine that someday targeted genetic **tests** could identify people carrying this favorable type of **variant**, potentially opening the door to personalized preventive **medicine** strategies tailored to each individual's specific inflammatory profile.

This prospect, though still distant, fits into a broader trend in **Western** **medicine** toward a preventive, personalized approach, where individual genetics increasingly guides health recommendations rather than standardized protocols applied uniformly across an entire population.

### A necessary ethical caution in the face of these prospects

This potential development also raises important ethical questions about equitable access to this type of advanced genetic testing, as well as the risks of genetic discrimination in areas such as health insurance or employment — issues Western regulators will need to anticipate before these technologies become widely available to the public.

I believe this regulatory foresight is just as important as the scientific research itself, because a beneficial discovery poorly governed on ethical and legal grounds could easily become a source of further inequality rather than a shared benefit for society as a whole.

*I get excited about this science while insisting on the urgency of solid **ethical** safeguards, because the history of genetics is full of examples where promising advances were twisted toward discriminatory ends for lack of sufficient guardrails.*

## Conclusion: one more piece in the puzzle of human aging

### A cautious but meaningful step toward better understanding

The discovery of this rare CGAS **gene** variant in long-lived Dutch **families** represents an additional step, cautious but meaningful, in the scientific understanding of the biological mechanisms that allow some people to age in better health for longer than others. The next steps, particularly the **killifish** studies, will be decisive in confirming or ruling out the real potential of this research lead.

This research also demonstrates the methodological value of studying entire families rather than isolated individuals, an approach that could become a standard model for future research into the genetics of longevity worldwide.

### Scientific patience required before any concrete hope

For the general public, the main takeaway from this discovery remains patience: longevity science advances in small, rigorous steps, and it will likely take many more years before this kind of fundamental research eventually translates into concrete applications benefiting human health on a large scale.

*I close with measured hope: this discovery will change no one's life tomorrow morning, but it beautifully illustrates how science moves forward patiently, family by family, variant by variant, toward a better understanding of human aging.*

**By Maxime Marquette, columnist**

## Columnist's transparency note

### Editorial stance

I am not a journalist but a **columnist and analyst**. My expertise lies in observing and analysing the geopolitical, economic and strategic dynamics that shape our world. My work is to take political strategies apart, to understand global economic movements, to put the decisions of international actors in context and to offer analytical perspectives on the changes that are redefining our societies.

I do not claim the cold objectivity of traditional journalism, which stops at reporting facts. **I claim analytical clarity**, rigorous interpretation and a deep understanding of the complex issues that concern us all. My role is to give meaning to the facts, to place them in their historical and strategic context, and to offer a critical reading of events.

### Method and sources

This text keeps the basic distinction between **verified facts and interpretive analysis**. The rule never changes: a factual claim is published only when a verifiable source supports it, and the sources this article actually used are listed under **Sources**, never here.

**Primary source families** used by the publication, when the story has them: official statements from governments and international institutions, public statements by political leaders, reports from intergovernmental organisations, dispatches from recognised international news agencies.

**Secondary source families**: specialised publications, internationally recognised news media, analyses from established research institutions, reports from industry organisations.

When an article cites statistical, economic or geopolitical data, it comes from the institutions that produce it (intergovernmental organisations, central banks, national statistics offices), and the exact institution is named under **Sources**.

### Nature of the analysis

The analyses, interpretations and perspectives in the analytical sections of this article are a **critical, contextual synthesis** based on the information available, the trends observed and the expert comments cited in the sources consulted.

My role is to interpret these facts, to set them in the context of today's geopolitical and economic dynamics, and to give them a coherent meaning within the larger story of the changes shaping our time. These analyses reflect expertise built through continuous observation of international affairs and an understanding of the strategic mechanisms that drive global actors.

This article describes a documented state of affairs on its publication date, not a prediction: later developments may shift its outlook. No update is promised in advance; when an article is corrected or completed, the change is dated in the text.

## Sources

### Primary sources

- ScienceDaily / European Society of Human Genetics, full results on the CGAS gene and longevity — June 21, 2026

- Micromolar, detailed coverage of the study on long-lived families — June 2026

### Secondary sources

- Medical Daily, analysis of the CGAS gene mutation and the STING pathway in the Leiden study — 2026

- Medical Xpress, intergenerational transmission of healthy longevity — June 2026

- Video report on longevity genetics research presented in Gothenburg — 2026

- European Society of Human Genetics, 2026 annual conference in Gothenburg — June 2026

---

Source: Maxime Marquette, MadMax. When citing, name the author and link https://mad-max.co/en/article/le-gene-qui-explique-pourquoi-certaines-familles-vieillissent-mieux-que-d-autres